Wang C R, Hashimoto K, Kubo S, Yokochi T, Kubo M, Suzuki M, Suzuki K, Tada T, Nakayama T
Department of Immunology, Faculty of Medicine, University of Tokyo, Japan.
J Exp Med. 1995 Mar 1;181(3):927-41. doi: 10.1084/jem.181.3.927.
The goal of this study was to identify the differences of intracellular signals between the processes of thymic positive and negative selection. The activation of calcineurin, a calcium- and calmodulin-dependent phosphatase, is known to be an essential event in T cell activation via the T cell receptor (TCR). The effect of FK506, an inhibitor of calcineurin activation, on positive and negative selection in CD4+CD8+ double positive (DP) thymocytes was examined in normal mice and in a TCR transgenic mouse model. In vivo FK506 treatment blocked the generation of mature TCRhighCD4+CD8- and TCRhighCD4-CD8+ thymocytes, and the induction of CD69 expression on DP thymocytes. In addition, the shutdown of recombination activating gene 1 (RAG-1) transcription and the downregulation of CD4 and CD8 expression were inhibited by FK506 treatment suggesting that the activation of calcineurin is required for the first step (or the very early intracellular signaling events) of TCR-mediated positive selection of DP thymocytes. In contrast, FK506-sensitive calcineurin activation did not appear to be required for negative selection based on the observations that negative selection of TCR alpha beta T cells in the H-2b male thymus (a negative selecting environment) was not inhibited by in vivo treatment with FK506 and that there was no rescue of the endogenous superantigen-mediated clonal deletion of V beta 6 and V beta 11 thymocytes in FK506-treated CBA/J mice. DNA fragmentation induced by TCR activation of DP thymocytes in vitro was not affected by FK506. In addition, different effects of FK506 from Cyclosporin A on the T cell development in the thymus were demonstrated. The results of this study suggest that different signaling pathways work in positive and negative selection and that there is a differential dependence on calcineurin activation in the selection processes.
本研究的目的是确定胸腺阳性和阴性选择过程中细胞内信号的差异。钙调神经磷酸酶是一种钙和钙调蛋白依赖性磷酸酶,其激活是已知的通过T细胞受体(TCR)进行T细胞激活的关键事件。在正常小鼠和TCR转基因小鼠模型中,研究了钙调神经磷酸酶激活抑制剂FK506对CD4+CD8+双阳性(DP)胸腺细胞阳性和阴性选择的影响。体内FK506处理阻断了成熟TCRhighCD4+CD8-和TCRhighCD4-CD8+胸腺细胞的产生,以及DP胸腺细胞上CD69表达的诱导。此外,FK506处理抑制了重组激活基因1(RAG-1)转录的关闭以及CD4和CD8表达的下调,这表明钙调神经磷酸酶的激活是TCR介导的DP胸腺细胞阳性选择第一步(或非常早期的细胞内信号事件)所必需的。相反,基于以下观察结果,阴性选择似乎不需要FK506敏感的钙调神经磷酸酶激活:H-2b雄性胸腺(阴性选择环境)中TCRαβT细胞的阴性选择不受体内FK506处理的抑制,并且在FK506处理的CBA/J小鼠中,内源性超抗原介导的Vβ6和Vβ11胸腺细胞克隆缺失没有得到挽救。体外TCR激活DP胸腺细胞诱导的DNA片段化不受FK506影响。此外,还证明了FK506与环孢素A对胸腺中T细胞发育的不同作用。本研究结果表明,阳性和阴性选择中存在不同的信号通路,并且在选择过程中对钙调神经磷酸酶激活存在不同的依赖性。